Five spine surgeons discuss where they expect technology to evolve over the next half-decade.

A new study published in Spine examines bone graft substitutes for one- and two-level anterior cervical discectomy and fusion.

Vail, Colo.-based Steadman Clinic's Matthew Provencher, MD, received AlloSource's Dr. Steven Gitelis Inspiration Award to recognize his work using donated human tissue to help patients heal.

Marietta, Ga.-based biopharmaceutical company MiMedx has appointed Timothy Wright as its new CEO.

Orthopedic surgeon at San Diego-based Grossmont Hospital Scott A. Hacker, MD, treated the first four patients in the west coast with medical device company CartiHeal's Agili-C cartilage regeneration implant.

San Antonio-based nonprofit BioBridge Global has added orthopedic surgeon Michael J. Yaszemski, MD, PhD, to its regenerative medicine advisory board.

New York-based medical device manufacturer Misonix agreed to acquire privately held wound-healing company Solys Medical of Newport News, Va., in an all-stock transaction valued at $97 million.

Biomedical engineers and researchers from North Carolina State University, N.C., have partnered with University of North Carolina, N.C., scientists to create new body tissues using a patient's own cells, which may help more patients avoid knee replacement surgery, reports WRAL, a local NBC affiliate in North Carolina.

A Montana therapeutic drug developer and California biotech company have agreed to collaborate on novel approaches for treating disorders of the central nervous system.

Stem cell treatments are experimental in orthopedics, but their use is promising, according to Jeffrey Carroll, MD.

A new study published in Spine examines hospital resource utilization for spine surgery patients who need treatment for Staphylococcus aureus infection with 180 days of surgery.

A new study from Market Research Gazette examines the spinal fusion market.

Altrua HealthShare and Regenexx partnered to offer Altrua members access to Regenexx's regenerative medicine treatments.

UC San Francisco department of orthopedic surgery researcher Annarita Scaramozza, PhD, has made a discovery that could boost recovery from radiation therapy for cancer treatment with 'super hero' stem cells.

A new study published in Spine compares open and Wiltse minimally invasive transforaminal lumbar interbody fusion outcomes. 

The interbody fusion cage market is expected to grow through 2025, according to a MarketReserachNest report.

Penn Engineering researchers recently examined stem cell transformation and found they could have more influence on shaping their environment and determining functionality, according to a Penn Today report.

Here are five trends on the evolution of spinal biologics and what to expect in the future.

Research presented at the Society for Minimally Invasive Spine Surgery Annual Forum in 2018 compares static and expandable interbody devices for minimally invasive transforaminal lumbar interbody fusion.

Spine surgery is shifting away from traditional devices and toward biologics, a material that attracts cells to increase bone formation in spinal fusion procedures, according to Jeffrey Wang, MD, who is the University of California-Los Angeles spine service chief and director of UCLA's spine surgery fellowship.